NAL Pharmaceutical Group Limited

NAL Pharmaceutical Group Limited


Company description

NAL is developing proprietary, non-infringing DDS drug products including rDNA-engineered tumor-targeting nanoparticle and microsphere extended-release injectables, transdermal patches, sublingual oral films, and solids, based on captive DDS.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Capsules |Creams, Lotions, Ointments |Injectables More

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 846 See our Exhibitor Profile   See full Exhibitor List
NAL Pharmaceutical Group Limited

Contact information




View all contact information